HHS considering action on Drug patents over High Prices.....

Discussion in 'Health Care' started by MMC, Feb 11, 2016.

  1. MMC

    MMC Well-Known Member

    Joined:
    Sep 4, 2012
    Messages:
    41,793
    Likes Received:
    14,697
    Trophy Points:
    113
    Gender:
    Male
    Democrats want to use March In Rights and have HHS issue guidelines on Administrative action to fight high drug prices. It was suppose to be used for price gouging. The Demos thought is if there are guidelines out there it will force the pharm companies from price hikes. What say ye?




    Health and Human Services Secretary Sylvia Burwell said Wednesday that her department is considering issuing guidelines on an executive action known as “march-in rights” as a way to fight high drug prices.

    At a Ways and Means Committee hearing on Wednesday, Burwell was asked about a letter from more than 50 House Democrats last month urging HHS to issue guidelines on the administrative action.

    Under a 1980 law, when federally-funded research was involved in creating a new drug, HHS can assert “march-in rights” to break a drug patent when the price is too high and not “available to the public on reasonable terms.”

    The lawmakers asked for HHS to issue guidelines “in response to price gouging” for when this power could be used, saying that just the issuance of guidelines could warn drug companies to avoid price hikes.....snip~

    http://thehill.com/policy/healthcare/269003-hhs-considering-action-on-drug-patents-over-high-prices
     

Share This Page